Veterinary Medicines

RABISIN MULTI, injekcinė suspensija

Authorised
  • Rabies virus, strain G52, Inactivated
Download as PDF

Identifikazzjoni tal-prodott

Isem tal-mediċina:
RABISIN MULTI, injekcinė suspensija
Sustanza attiva:
Speċi li fuqhom ser jintuża l-prodott:
Metodu ta’ amministrazzjoni:
  • Użu għal taħt il-ġilda
  • Użu għal ġol-muskoli

Dettalji tal-prodott

Sustanza attiva / Qawwa:
  • Disponibbli biss fi English
    1.00
    international unit(s)
    /
    1.00
    Dose
Forma farmaċewtika:
  • Suspensjoni għall-injezzjoni
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
    • Cat
    • Cattle
      • Meat and offal, milk
        0
        day
    • Sheep
      • Meat and offal, milk
        0
        day
    • Ferret
  • Intramuscular use
    • Dog
    • Cat
    • Horse
      • Meat and offal, milk
        0
        day
    • Cattle
      • Meat and offal, milk
        0
        day
    • Sheep
      • Meat and offal, milk
        0
        day
    • Ferret
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
  • QI07AA02
Status legali tal-provvista:
Status tal-awtorizzazzjoni:
  • Valid
Authorised in:
  • Lithuania
Deskrizzjoni tal-pakkett:

Tagħrif addizzjonali

Entitlement type:
Bażi ġuridika tal-awtorizzazzjoni tal-prodott:
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
  • Boehringer Ingelheim Animal Health France
Awtorità responsabbli:
  • SFVS
Numru tal-awtorizzazzjoni:
  • LT/2/11/2029/001
Data tal-bidla fl-istatus tal-awtorizzazzjoni:

Dokumenti

RV2029.pdf

Lithuanian (PDF)
Ippubblikat fuq: 28/06/2022
Niżżel
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."